#USA #San Francisco #House Rx #Gastro Health #Medically Integrated

Gastro Health and House Rx Collaborate to Enhance Patient Medication Access

In an innovative move to improve patient care, Gastro Health, one of the largest gastroenterology practices in the nation, has joined forces with House Rx, a pioneer in medically integrated dispensing solutions. This partnership aims to modernize the way patients access their prescribed gastroenterology medications by implementing an in-office dispensing program across Gastro Health’s extensive network of care centers.

Reducing Wait Times

With patient-centered care at the forefront of this strategic alliance, both organizations have emphasized the need to reduce the time between a physician's order and a patient receiving their therapy. According to Philip Meador, the Chief Operating Officer of Gastro Health, their leadership team recognized that expediting access to gastroenterological treatments was vital for improving patient outcomes. By collaborating with House Rx, they aim to streamline the process, enabling patients to transition from prescription to therapy in a fraction of the time required by conventional specialty pharmacies.

A Focus on Patient-Centric Solutions

House Rx has built a reputation for its modernized approach to dispensing medications, which includes AI-native services supported by a vast network of experts. This alignment with Gastro Health’s values—placing the patient experience at the center of healthcare—was a significant factor in Gastro Health’s decision. Alerie Stiles, Senior Vice President of Commercial Growth at House Rx, highlighted the inspiring drive that Gastro Health's leadership has shown in reimagining medication access for their patients.

Key Benefits of the Partnership

The partnership between Gastro Health and House Rx is designed to yield multiple benefits for both the clinics and the patients. Some of the key advantages include:

• - Faster Time to First Dose: Patients will benefit from a quicker transition from prescription to medication, significantly reducing the delays commonly associated with traditional pharmacy processes.
• - Improved Patient Outcomes: By ensuring prompt delivery of therapy, the collaboration aims to enhance medication adherence and overall patient health, facilitated by House Rx’s experienced clinical teams.
• - Dedicated Support: The partnership will integrate hundreds of specialty pharmacists and care coordinators from House Rx directly into Gastro Health’s clinical workflow, providing patients with personalized assistance throughout their treatment journeys.

About the Involved Entities

Gastro Health

Gastro Health is a leading gastroenterology platform in the United States, encompassing practices across multiple states, including Alabama, Florida, Maryland, Massachusetts, Ohio, Virginia, and Washington. With over 350 physicians and 150 operational locations—including medical offices, infusion centers, imaging services, and a specialty pharmacy—Gastro Health is dedicated to offering high-quality care and a superior healthcare experience. Utilizing cutting-edge technology and compassionate clinical expertise, they deliver tailored approaches to digestive health and wellness.

House Rx

House Rx stands out as the only AI-native services provider focused on making specialty medications more accessible and affordable for patients. Partnering with over 2,000 providers nationwide, they connect pharmacists and care coordinators directly with healthcare teams, facilitating medically integrated dispensing and embedded pharmacies. Their model is designed to expedite the path from prescription to treatment, reduce healthcare costs, and improve the overall patient experience.

Conclusion

The collaboration between Gastro Health and House Rx illustrates a forward-thinking approach to healthcare, centered around enhancing patient experiences and outcomes. By prioritizing accessibility and personalized support, they are setting a new standard for how specialty medications are managed and dispensed. This partnership is not just about immediate benefits; it signifies a commitment to evolving the future of patient care in gastroenterology. As the healthcare landscape continues to change, such innovations will be essential in meeting the diverse needs of patients effectively.